tiprankstipranks
pc:viver

Vivere Oncotherapies

Vivere Oncotherapies is a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors. The company leverages a proprietary bioengineering platform to design targeted immunotherapies that reach tumors more efficiently and provide treatments for difficult-to-treat solid tumors such as colorectal and ovarian cancers.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 13, 2026
Investment
$10.00M

Investors

Investor Name
Funding Round

Related News and Analysis